Snapshot · Russell 3000 · generated 2026-10-17 22:05 UTC
ASTH — Astrana Health, Inc.
EXPENSIVE (MOS -50.8%) · Quality 69/100
Price
36.81
Intrinsic value
24.41
Margin of safety
-50.8%
Implied growth (reverse DCF)
+20.5%
model assumes +12.7%
Value Score
19.3
Quality
69
Psychology
19
Discovery
7.5
price/volume attention only
Moat score
7.1
erosion: none
Value Score: bottom 31% of Russell 3000 · Quality: top 18%
Open the interactive Deep Dive for ASTH →
Use this data programmatically
This page's numbers are also available as JSON at /api/v1/deep-dive/ASTH - see the API docs for the full read-only surface, including an MCP server for AI assistants.
Common questions
Is ASTH undervalued?
As of 2026-10-17, ASTH trades at 36.81 against a computed intrinsic value of 24.41 (-50.8% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.
What is Astrana Health, Inc.'s Value Score?
Astrana Health, Inc.'s Value Score is 19.3 as of 2026-10-17 - it combines value, quality, crowd psychology and market attention into one number.